Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update

This is a clinical practice guideline for patients with multiple myeloma. The guideline examines the role of bone-modifying agents (BMAs) in this patient population. Topics of interest include indications to initiate treatment with a BMA, dosing and selection of BMAs, duration of therapy, and monitoring response.